StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock.
Separately, Zacks Investment Research downgraded Neptune Wellness Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, April 13th.
Shares of NASDAQ NEPT opened at $0.15 on Friday. Neptune Wellness Solutions has a one year low of $0.13 and a one year high of $1.49. The firm has a market capitalization of $28.46 million, a PE ratio of -0.25 and a beta of 2.07. The company has a current ratio of 1.75, a quick ratio of 1.07 and a debt-to-equity ratio of 0.12. The business has a 50-day moving average price of $0.20 and a two-hundred day moving average price of $0.33.
Neptune Wellness Solutions Company Profile (Get Rating)
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.